亿胜生物科技有限公司（股票代码：01061）于2026年4月1日披露了截至2026年3月31日的股份变动月报表。报告显示，公司本月无新增发行、购回或注销股份，整体股本结构保持不变。
根据公告，截至3月31日，公司法定注册股本仍为1,000,000,000股，面值每股0.1港元，对应注册股本总额为1亿港元。已发行股份数量维持在567,006,000股，与上月末保持一致，未持有任何库藏股份。
公告同时显示，2023年6月9日经股东大会通过的购股权计划下，可供行使的股份期权数量仍为57,064,900股，本月无新增行使或失效记录，亦无因此发行或转让股份的情况。
公司确认继续符合香港联交所规定的公众持股量要求。本次月报由公司董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.